ISPOR International Meeting Come find the CEVR team at booth #309. See a list of conference presentations from our researchers here.
21st Century Cures Act CEVR researchers have a new post, originally on the Health Affairs Blog, about implications for drug company promotion of real-world data
Our Spring 2015 Newsletter is available here.
CEA Registry update The Registry has now been updated through 2013. The database now includes a total of 4,339 cost-utility analyses and 11,880 cost-effectiveness ratios.
Growth and change in the CUA literature CEVR researchers published a new paper in Value in Health: “The Changing Face of the Cost-Utility Literature."